These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23193911)

  • 1. Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.
    Li W; Zhai L; Tang Y; Cai J; Liu M; Zhang J
    Oncol Res; 2012; 20(2-3):49-59. PubMed ID: 23193911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma.
    Li W; Cai JH; Zhang J; Tang YX; Wan L
    Int J Mol Sci; 2012; 13(8):9741-9753. PubMed ID: 22949827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.
    Li W; Wang J; Jiang HR; Xu XL; Zhang J; Liu ML; Zhai LY
    Int J Mol Sci; 2011 Jan; 12(1):668-81. PubMed ID: 21340007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts.
    Li W; Tang YX; Wan L; Cai JH; Zhang J
    Oncol Lett; 2013 Mar; 5(3):923-928. PubMed ID: 23426648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.
    Li W; Wan L; Zhai LY; Wang J
    Int J Mol Sci; 2014 Oct; 15(10):19265-80. PubMed ID: 25342321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.
    Li W; Jiang HR; Xu XL; Wang J; Zhang J; Liu ML; Zhai LY
    Int J Mol Sci; 2010 Oct; 11(10):3999-4013. PubMed ID: 21152316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer.
    Zhang DQ; Guo Q; Zhu JH; Chen WC
    World J Surg Oncol; 2013 Jan; 11():16. PubMed ID: 23347845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.
    Li W; Xu RJ; Lin ZY; Zhuo GC; Zhang HH
    Med Oncol; 2009; 26(2):170-7. PubMed ID: 18988002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.
    Li W; Liu ML; Cai JH; Tang YX; Zhai LY; Zhang J
    Oncol Lett; 2012 Jul; 4(1):168-174. PubMed ID: 22807982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
    Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
    Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumoral effect of a celecoxib low dose on a model of human medullary thyroid cancer in nude mice.
    Quidville V; Segond N; Tebbi A; Cohen R; Jullienne A; Lepoivre M; Lausson S
    Thyroid; 2009 Jun; 19(6):613-21. PubMed ID: 19281427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].
    Ran JT; Zhou YN; Tang CW; Lu JR; Wu J; Lu H; Yang GD
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):448-51. PubMed ID: 19024521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
    Zhao Y; Hao Y; Ji H; Fang Y; Guo Y; Sha W; Zhou Y; Pang X; Southerland WM; Califano JA; Gu X
    Cancer Prev Res (Phila); 2010 Jun; 3(6):787-96. PubMed ID: 20501859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
    Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
    World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of ovarian carcinoma in vivo.
    Li W; Zhang HH; Xu RJ; Zhuo GC; Hu YQ; Li J
    Med Oncol; 2008; 25(2):172-7. PubMed ID: 18488158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
    Rao CV; Steele VE; Swamy MV; Patlolla JM; Guruswamy S; Kopelovich L
    Cancer Res; 2009 Oct; 69(20):8175-82. PubMed ID: 19826045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.
    Park W; Oh YT; Han JH; Pyo H
    J Exp Clin Cancer Res; 2008 Nov; 27(1):66. PubMed ID: 19000324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.